Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis

Vijay P. Singh, Gary D. Bren, Alicia Algeciras-Schimnich, David Schnepple, Sarah Navina, Stacey A. Rizza, Rajinder Dawra, Ashok Saluja, Suresh T. Chari, Santhi S. Vege, Andrew D. Badley

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

There is no clinical treatment that reduces acinar injury during pancreatitis. Human immunodeficiency virus (HIV) protease inhibitors (PI), including nelfinavir (NFV) and ritonavir (RTV), may reduce the rate of pancreatitis in HIV-infected patients. Since permeability transition pore (PTPC)-mediated mitochondrial dysfunction occurs during pancreatitis, and we have shown that PI prevents PTPC opening, we studied its effects in a model of pancreatitis. The effect of NFV plus RTV (NFV/RTV) or vehicle on caerulein-induced pancreatitis in mice was compared by measuring changes in mitochondrial membrane potential in vitro and cytochrome c leakage in vivo. Histological and inflammatory makers were also compared. NFV/RTV improved DiOC6 retention in acini exposed to caerulein in vitro. In vivo NFV prevented cytosolic leakage of cytochrome c and reduced pancreatic acinar injury, active caspase-3 staining, TUNEL-positive acinar cells, and serum amylase (P < 0.05). Conversely, trypsin activity, serum cytokine levels, and pancreatic and lung inflammation were unaffected. NFV/RTV reduces pancreatic injury and acinar cell death in experimental mouse caerulein-induced pancreatitis but does not impact inflammation.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume296
Issue number5
DOIs
StatePublished - May 1 2009
Externally publishedYes

Fingerprint

Nelfinavir
Ceruletide
Ritonavir
Pancreatitis
Inflammation
Wounds and Injuries
Acinar Cells
Cytochromes c
Protease Inhibitors
HIV
Mitochondrial Membrane Potential
In Situ Nick-End Labeling
Amylases
Serum
Caspase 3
Trypsin
Permeability
Pneumonia
Cell Death
Staining and Labeling

Keywords

  • Apoptosis
  • Necrosis
  • Permeability transition pore inhibition
  • Protease inhibitors

ASJC Scopus subject areas

  • Gastroenterology
  • Physiology (medical)
  • Physiology
  • Hepatology

Cite this

Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis. / Singh, Vijay P.; Bren, Gary D.; Algeciras-Schimnich, Alicia; Schnepple, David; Navina, Sarah; Rizza, Stacey A.; Dawra, Rajinder; Saluja, Ashok; Chari, Suresh T.; Vege, Santhi S.; Badley, Andrew D.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 296, No. 5, 01.05.2009.

Research output: Contribution to journalArticle

Singh, Vijay P. ; Bren, Gary D. ; Algeciras-Schimnich, Alicia ; Schnepple, David ; Navina, Sarah ; Rizza, Stacey A. ; Dawra, Rajinder ; Saluja, Ashok ; Chari, Suresh T. ; Vege, Santhi S. ; Badley, Andrew D. / Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2009 ; Vol. 296, No. 5.
@article{c952a9ca947c4d9f82390f8ca3273043,
title = "Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis",
abstract = "There is no clinical treatment that reduces acinar injury during pancreatitis. Human immunodeficiency virus (HIV) protease inhibitors (PI), including nelfinavir (NFV) and ritonavir (RTV), may reduce the rate of pancreatitis in HIV-infected patients. Since permeability transition pore (PTPC)-mediated mitochondrial dysfunction occurs during pancreatitis, and we have shown that PI prevents PTPC opening, we studied its effects in a model of pancreatitis. The effect of NFV plus RTV (NFV/RTV) or vehicle on caerulein-induced pancreatitis in mice was compared by measuring changes in mitochondrial membrane potential in vitro and cytochrome c leakage in vivo. Histological and inflammatory makers were also compared. NFV/RTV improved DiOC6 retention in acini exposed to caerulein in vitro. In vivo NFV prevented cytosolic leakage of cytochrome c and reduced pancreatic acinar injury, active caspase-3 staining, TUNEL-positive acinar cells, and serum amylase (P < 0.05). Conversely, trypsin activity, serum cytokine levels, and pancreatic and lung inflammation were unaffected. NFV/RTV reduces pancreatic injury and acinar cell death in experimental mouse caerulein-induced pancreatitis but does not impact inflammation.",
keywords = "Apoptosis, Necrosis, Permeability transition pore inhibition, Protease inhibitors",
author = "Singh, {Vijay P.} and Bren, {Gary D.} and Alicia Algeciras-Schimnich and David Schnepple and Sarah Navina and Rizza, {Stacey A.} and Rajinder Dawra and Ashok Saluja and Chari, {Suresh T.} and Vege, {Santhi S.} and Badley, {Andrew D.}",
year = "2009",
month = "5",
day = "1",
doi = "10.1152/ajpgi.90642.2008",
language = "English (US)",
volume = "296",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis

AU - Singh, Vijay P.

AU - Bren, Gary D.

AU - Algeciras-Schimnich, Alicia

AU - Schnepple, David

AU - Navina, Sarah

AU - Rizza, Stacey A.

AU - Dawra, Rajinder

AU - Saluja, Ashok

AU - Chari, Suresh T.

AU - Vege, Santhi S.

AU - Badley, Andrew D.

PY - 2009/5/1

Y1 - 2009/5/1

N2 - There is no clinical treatment that reduces acinar injury during pancreatitis. Human immunodeficiency virus (HIV) protease inhibitors (PI), including nelfinavir (NFV) and ritonavir (RTV), may reduce the rate of pancreatitis in HIV-infected patients. Since permeability transition pore (PTPC)-mediated mitochondrial dysfunction occurs during pancreatitis, and we have shown that PI prevents PTPC opening, we studied its effects in a model of pancreatitis. The effect of NFV plus RTV (NFV/RTV) or vehicle on caerulein-induced pancreatitis in mice was compared by measuring changes in mitochondrial membrane potential in vitro and cytochrome c leakage in vivo. Histological and inflammatory makers were also compared. NFV/RTV improved DiOC6 retention in acini exposed to caerulein in vitro. In vivo NFV prevented cytosolic leakage of cytochrome c and reduced pancreatic acinar injury, active caspase-3 staining, TUNEL-positive acinar cells, and serum amylase (P < 0.05). Conversely, trypsin activity, serum cytokine levels, and pancreatic and lung inflammation were unaffected. NFV/RTV reduces pancreatic injury and acinar cell death in experimental mouse caerulein-induced pancreatitis but does not impact inflammation.

AB - There is no clinical treatment that reduces acinar injury during pancreatitis. Human immunodeficiency virus (HIV) protease inhibitors (PI), including nelfinavir (NFV) and ritonavir (RTV), may reduce the rate of pancreatitis in HIV-infected patients. Since permeability transition pore (PTPC)-mediated mitochondrial dysfunction occurs during pancreatitis, and we have shown that PI prevents PTPC opening, we studied its effects in a model of pancreatitis. The effect of NFV plus RTV (NFV/RTV) or vehicle on caerulein-induced pancreatitis in mice was compared by measuring changes in mitochondrial membrane potential in vitro and cytochrome c leakage in vivo. Histological and inflammatory makers were also compared. NFV/RTV improved DiOC6 retention in acini exposed to caerulein in vitro. In vivo NFV prevented cytosolic leakage of cytochrome c and reduced pancreatic acinar injury, active caspase-3 staining, TUNEL-positive acinar cells, and serum amylase (P < 0.05). Conversely, trypsin activity, serum cytokine levels, and pancreatic and lung inflammation were unaffected. NFV/RTV reduces pancreatic injury and acinar cell death in experimental mouse caerulein-induced pancreatitis but does not impact inflammation.

KW - Apoptosis

KW - Necrosis

KW - Permeability transition pore inhibition

KW - Protease inhibitors

UR - http://www.scopus.com/inward/record.url?scp=66149105496&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149105496&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.90642.2008

DO - 10.1152/ajpgi.90642.2008

M3 - Article

C2 - 19282375

AN - SCOPUS:66149105496

VL - 296

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 5

ER -